THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ NEW YORK, March 8, 2021 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) (“MindMed” or the “Company”), a leading psychedelic medicine biotech company, is pleased to announce that it has entered…

Source

Previous articlePsychedelic Speech: How Drugs Disorganize Normal Communication Patterns
Next articleCOMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020